Select Medical (NYSE:SEM) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Select Medical (NYSE:SEM) issued its quarterly earnings results on Thursday. The health services provider reported $0.60 EPS for the quarter, missing the consensus estimate of $0.61 by ($0.01), Briefing.com reports. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.88%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.61 EPS. Select Medical updated its FY 2024 guidance to 1.960-2.200 EPS and its FY24 guidance to $1.96-2.20 EPS.

Select Medical Stock Down 12.8 %

Shares of SEM stock traded down $5.00 during mid-day trading on Friday, reaching $34.18. 2,367,259 shares of the company were exchanged, compared to its average volume of 708,812. The company has a market capitalization of $4.44 billion, a P/E ratio of 16.28, a P/E/G ratio of 1.78 and a beta of 1.43. The business’s 50 day simple moving average is $35.77 and its 200 day simple moving average is $31.16. The company has a debt-to-equity ratio of 2.30, a quick ratio of 1.22 and a current ratio of 1.22. Select Medical has a fifty-two week low of $21.28 and a fifty-two week high of $40.50.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be given a dividend of $0.125 per share. The ex-dividend date is Wednesday, August 14th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.46%. Select Medical’s payout ratio is currently 23.81%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on SEM shares. Royal Bank of Canada lifted their target price on Select Medical from $36.00 to $40.00 and gave the stock an “outperform” rating in a research report on Monday, May 6th. Benchmark reissued a “buy” rating and set a $48.00 target price on shares of Select Medical in a research note on Friday. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $36.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.